A Review of Pediatric Drug Development Programs and FDA Labeling for Immunosuppressive Drugs in Organ Transplant Patients.

被引：0
|
作者：
Burckart, G. [1 ]
Cavaille-Coll, M. [2 ]
Duong, A. [3 ]
Hothem, L. [4 ]
Albrecht, R. [2 ]
机构：
[1] US FDA, Off Clin Pharmacol, Off Translat Sci, CDER, Silver Spring, MD USA
[2] US FDA, Div Transplant & Opthalmol Prod, Off New Drugs, CDER, Silver Spring, MD USA
[3] Tauro Univ, New York, NY USA
[4] Univ N Carolina, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B245
引用
收藏
页码：714 / 714
页数：1
相关论文
共 44 条
  • [1] Influence of immunosuppressive drugs on circulating dendritic cells in stable renal transplant patients.
    Lim, WH
    Russ, GR
    Coates, PT
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 221 - 222
  • [2] Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
    Gu, Guangxiang
    Zhou, Tao
    Zong, Zhipeng
    Zhang, Jianjun
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [3] The Prevalence and Use of Psychiatric Medications in Pediatric Solid Organ Transplant Patients.
    Fribley, Corinne
    Croarkin, Paul
    Gross, Jami
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 620 - 620
  • [4] Viral Gastroenteritis in Adult and Pediatric Solid Organ Transplant (SOT) Patients.
    Garcia, C. Hernandez
    Lee, B.
    Pang, X.
    Zhou, H. Yuan
    Preikisatis, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 294 - 295
  • [5] Pharmacodynamic Monitoring of Immunosuppressive Drugs in Pediatric Kidney, Heart and Liver Transplant Patients
    Lapeyraque, A. L.
    Brito, R. M.
    Durrieu, V.
    Clermont, M. J.
    Theoret, Y.
    Le Deist, F.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1891 - 1891
  • [6] Adverse Event Detection and Labeling in Pediatric Drug Development: Antiretroviral Drugs
    Momper, Jeremiah D.
    Chang, Yang
    Jackson, Matthew
    Schuette, Paul
    Seo, Shirley
    Younis, Islam
    Abernethy, Darrell R.
    Yao, Lynne
    Capparelli, Edmund V.
    Burckart, Gilbert J.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (02) : 302 - 309
  • [7] Adverse Event Detection and Labeling in Pediatric Drug Development: Antiretroviral Drugs
    Jeremiah D. Momper
    Yang Chang
    Matthew Jackson
    Paul Schuette
    Shirley Seo
    Islam Younis
    Darrell R. Abernethy
    Lynne Yao
    Edmund V. Capparelli
    Gilbert J. Burckart
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 302 - 309
  • [8] Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review
    Boulay, Hugoline
    Mazaud-Guittot, Severine
    Supervielle, Jeanne
    Chemouny, Jonathan M.
    Dardier, Virginie
    Lacroix, Agnes
    Dion, Ludivine
    Vigneau, Cecile
    CLINICAL KIDNEY JOURNAL, 2021, 14 (08) : 1871 - 1878
  • [9] Pediatric drug development programs for type 2 diabetes: A review
    Christensen, Michael L.
    Franklin, Brandi E.
    Momper, Jeremiah D.
    Reed, Michael D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (07): : 731 - 738
  • [10] Risk Factors for Development of Opportunistic Infections in Pediatric Renal Transplant Patients.
    Jordan, C.
    Taber, D.
    Pilch, N.
    Fleming, J.
    Oliver, M.
    Connelly, J.
    Nadig, S.
    Lin, A.
    McGillicuddy, J.
    Shatat, I.
    Twombley, K.
    Chavin, K.
    Baliga, P.
    TRANSPLANTATION, 2014, 98 : 498 - 498
12345